Acarbose might be associated with reduced risk of gastric cancer in patients with diabetes mellitus: A nationwide population‐based cohort study

2024-9-1

Detecting and Dating Early Non‐live Pregnancy Outcomes: Generation of a Novel Pregnancy Algorithm From Norwegian Linked Health Registries

2024-9-1

Sharing Is Caring? International Society for Pharmacoepidemiology Review and Recommendations for Sharing Programming Code

2024-9-1

Strengthening Real‐World Evidence on Question Not Answered by Randomized Trials: A Trial Calibration Approach

2024-9-1

Association Between Influenza Vaccination and Acute Kidney Injury Among the Elderly: A Self‐Controlled Case Series

2024-9-1

An Emulated Target Trial Case Study of Real‐World Overall Survival With Second‐Line Maintenance Niraparib Versus Active Surveillance in Patients With Recurrent Ovarian Cancer

2024-9-1

<scp>PMDA</scp> Perspective on <scp>RWD</scp>/<scp>RWE</scp> Utilization for Regulatory Purposes Including Assessment on the Impacts of Regulatory Actions and Safety Risk of a Drug at Postmarketing Stage

2024-9-1

Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Association With the Swissmedic Safety Alert Regarding Non‐melanoma Skin Cancer: An Interrupted Time‐Series Analysis Using Swiss Claims Data

2024-9-1

A Two‐Step Framework for Validating Causal Effect Estimates

2024-9-1

Hazard Ratios and Alternative Effect Measures: An Applied Illustration

2024-8-30

Contemporary Practice and Considerations for Real‐World Data Source Identification and Feasibility Assessment

2024-8-30

Potentially Inappropriate Medication Use in Older Adults With Multimorbidity in Taiwan

2024-8-30

Quantitative Measurement of the Direct Public Health Impact of Medicines Withdrawals in Europe: Development of a Modelling Method and Proof‐of‐Concept Study to Estimate the Morbidity and Mortality Prevented by Regulatory Action

2024-8-30

Standardization of coding definitions for sickle cell disease complications: A systematic literature review

2024-8-28

Issue Information

2024-8-28

Lack of Evidence for Vaccine‐Associated Enhanced Disease From <scp>COVID</scp>‐19 Vaccines Among Adults in the Vaccine Safety Datalink

2024-8-1

Evaluation of Medication Adherence Among Prevalent Users in Hypertension, Dyslipidemia, and Diabetes Using Health Insurance Claims: A Population‐Based Cohort Study in Japan

2024-8-1

Prevalence, Associated Risk Factors, and Adverse Cardiovascular Outcomes of Statins Discontinuation: A Systematic Review

2024-8-1

Adverse Menstrual Events Reported After and Before (or Without) COVID‐19 Vaccination: A Systematic Review and Meta‐Analysis of Comparative Observational Studies

2024-8-1

Disparity in Guideline‐Based Antidiabetic Drugs Prescribing for Type 2 Diabetes Patients in Primary Healthcare Facilities Across China, 2017–2019

2024-8-1

A New Validated Approach for Identifying Childhood Immunizations in Electronic Health Records in the United Kingdom

2024-8-1

Leftover of Amoxicillin Suspension After Use by Children in the Netherlands

2024-8-1

Pain Medication and Pain Intensity Following Hip Fractures—Analyses Based on the <scp>ProFem</scp> Cohort Study

2024-8-1

Validation of a Major and Clinically Relevant Nonmajor Bleeding Phenotyping Algorithm on Electronic Health Records

2024-8-1

The Medicines Intelligence Data Platform: A Population‐Based Data Resource From New South Wales, Australia

2024-8-1

A Review of Concordance and Quality in Clinical Guidelines for Hormonal Contraceptives to Mitigate Drug–Drug Interactions in Women With Epilepsy

2024-8-1

Prevalence of Polypharmacy in Elderly Population Worldwide: A Systematic Review and Meta‐Analysis

2024-8-1

Studying the Impact of European Union Regulatory Interventions for Minimising Risks From Medicines: Lessons Learnt and Recommendations

2024-8-1

Pregnancy and Infant Outcomes After Prenatal Exposure to Golimumab in Denmark, Finland, and Sweden 2006–2019

2024-8-1

A Dynamic Prognostic Model for Identifying Vulnerable <scp>COVID</scp>‐19 Patients at High Risk of Rapid Deterioration

2024-8-1

Trends in the Completeness and Validity of Sources of Death Data Against the National Death Index From 2010 to 2018

2024-8-1

Issue Information

2024-8-1

The Effect of Sodium Glucose Cotransporter‐2 Inhibitors on Hemoglobin A1c Variability and Acute Kidney Injury: A Causal Mediation Analysis

2024-8-1

Rhekiss—The German Register for Child Wish and Pregnancies in Inflammatory Rheumatic Diseases

2024-8-1

Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Development and Pilot of a Metadata List and Catalogue in Europe

2024-8-1

Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Lessons Learnt From the MINERVA Project in Europe

2024-8-1

Real world prescription of beta‐blockers in patients with asthma

2024-8-1

The Comparison of Newly Diagnosed Invasive Breast Patient Cohorts in Genomics Evidence Neoplasia Information Exchange Biopharma Collaborative (<scp>GENIE</scp>‐<scp>BPC</scp>) and Other Real‐World Databases

2024-8-1

Risk of Suicidal Ideation and Behavior Following Early‐Onset Idiopathic Restless Legs Syndrome Treatment

2024-8-1

Nirmatrelvir/Ritonavir (Paxlovid) Use Among Individuals at Risk of Severe <scp>COVID</scp>‐19: An Analysis of the National <scp>COVID</scp> Cohort Collaborative (N3C)

2024-8-1

Analysis of Longitudinal Patterns and Predictors of Medicine Use in Residential Aged Care Using Group‐Based Trajectory Modeling: The “<scp>MEDTRAC</scp>‐Cardiovascular” Longitudinal Cohort Study

2024-8-1

Opioid Use and the Risk of Ventricular Arrhythmias: A Systematic Review and Meta‐Analysis

2024-8-1

Abstracts

2024-7-1

Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events

2024-7-1

Use of Azithromycin Attributable to Acute <scp>SARS</scp>‐<scp>CoV</scp>‐2 Infection

2024-7-1

Issue Information

2024-7-1